Annamaria Petrungaro

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Salvatore Campo, Alessandro Allegra, Caterina Musolino, 2012, International journal of oncology.

Venetoclax for the treatment of chronic lymphocytic leukemia

F. Morabito, M. Gentile, E. Vigna, 2017, Expert opinion on investigational drugs.

Iron overload and malignancies in patients with haemoglobinopathies: A single center experience.

L. Rigoli, R. Caruso, Annamaria Petrungaro, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera

A. Allegra, S. Campo, A. Alonci, 2011, Leukemia & lymphoma.

Prothrombotic role of antiphospholipid antibodies in a patient with sickle cell disease

L. Rigoli, Annamaria Petrungaro, P. Sciarrone, 2022, AIMS Medical Science.

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.

R. Foà, A. Neri, A. Guarini, 2017, Leukemia research.

Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

F. Mandelli, G. Gaidano, F. Cottone, 2016, American journal of hematology.

Evaluation of interleukin-23 plasma levels in patients with polycythemia vera and essential thrombocythemia.

A. Allegra, S. Gangemi, A. Alonci, 2012, Cellular immunology.

Pomalidomide in multiple myeloma

F. Morabito, M. Gentile, E. Vigna, 2017, Expert opinion on pharmacotherapy.

Lenalidomide and low‐dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials

A. Larocca, F. Gay, S. Bringhen, 2017, American journal of hematology.

Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant

C. Musolino, F. Morabito, M. Gentile, 2017, Chemotherapy.

Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602

A. Allegra, A. Alonci, S. Russo, 2012, Acta oncologica.

Decreased Plasma Levels of IL-33 Could Contribute to the Altered Function of Th2 Lymphocytes in Patients with Polycythemia Vera and Essential Thrombocythemia

A. Allegra, S. Gangemi, A. Alonci, 2013, Cancer Investigation.